Print  |  Close

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)


Active: Yes
Cancer Type: Lung Cancer
Unknown Primary
NCT ID: NCT06312137
Trial Phases: Phase III Protocol IDs: 2870-019 (primary)
NCI-2024-05549
2023-508012-35
jRCT2021240020
MK-2870-019
U1111-1297-4260
Eligibility: 18 Years and older, Male and Female Study Type: Treatment
Study Sponsor: Merck Sharp and Dohme LLC
NCI Full Details: http://clinicaltrials.gov/show/NCT06312137

Summary

This study will assess if adding sacituzumab tirumotecan with pembrolizumab after surgery
is effective in treating NSCLC for participants not achieving pathological complete
response. The primary hypothesis of this study is sacituzumab tirumotecan plus
pembrolizumab is superior to pembrolizumab monotherapy with respect to disease free
survival (DFS) as assessed by blinded independent central review (BICR).

Treatment Sites in Georgia

Atlanta Cancer Care - Canton
460 Northside Cherokee Blvd
Suite 450
Canton, GA 30115
atlantacancercare.com



Atlanta Cancer Care - Cumming
1505 Northside Boulevard
Suite 4600
Cumming, GA 30041
404-303-3355
www.atlantacancercare.com



City of Hope Atlanta
600 Celebrate Life Parkway
Newnan, GA 30265
770-400-6169
www.cityofhope.org/locations/atlanta/atlanta-cancer-center



Georgia Cancer Specialists - CenterPointe
1100 Johnson Ferry Road
Suite 600
Sandy Springs, GA 30342
404-256-4777 ext 9242
www.gacancer.com



Nancy N. and J.C. Lewis Cancer Research Pavilion at St. Joseph Candler
225 Candler Drive
Savannah, GA 31405
912-819-5778
www.sjchs.org



Northside Hospital Cancer Institute
1000 Johnson Ferry Road NE
Atlanta, GA 30342
404-303-3355
www.northside.com



Suburban Hematology-Oncology Associates - Duluth
3855 Pleasant Hill Road
Suite 480
Duluth, GA 30096
www.cancergwinnett.com

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.